Biologic therapies in the treatment of sarcoidosis.

Related Articles

Biologic therapies in the treatment of sarcoidosis.

Expert Rev Clin Immunol. 2016 Aug;12(8):817-25

Authors: Saketkoo LA, Baughman RP

Abstract
Sarcoidosis is a disease of remarkable heterogeneity in organ manifestation, severity and natural history, characterized by the presence of non-caseating granulomas. The majority of cases are acute and self-limited or remit with short courses of glucocorticoids; however, a proportion progress to a life-threatening obliterative fibrotic type associated with significant disability related to pulmonary, cardiac, ocular or central nervous system involvement. Biologic agents have been demonstrated in the successful treatment of refractory organ-threatening sarcoidosis; and though sarcoidosis remains elusive in predictability of progression, strong evidence suggests an indisputably efficacious role for these agents in efforts to stave morbidity and mortality related to sarcoidosis. This paper provides a review of sarcoidosis mechanistic etiopathogenesis to highlight the hypothetical underpinnings of the utility and concerns of current biologic treatments in current use and the potential future applications of newer agents and those under development.

PMID: 27117719 [PubMed - indexed for MEDLINE]

from #PubMed 1 via ola Kala on Inoreader http://ift.tt/2pOAZOg
via IFTTT

http://ift.tt/2qVK0Fk